Featured News

GHTC's policy report Achieving a bold vision for global health: Policy solutions to advance global health R&D was cited in an op-ed in the Huffington Post on the tuberculosis epidemic.

Learn More
GHTC issues statement on CEWG follow-up, R&D observatory at WHO Executive board meeting

GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board welcoming progress by WHO in operationalizing a Global Observatory on Health Research and Development as a follow-up to the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG). The statement, which was issued in partnership with the Global Health Council, also encouraged member states to fully fund the observatory and recommended diverse global health stakeholders be consulted as the process moves forward.

PDF
GHTC issues statement on antimicrobial resistance at WHO Executive Board meeting

GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board supporting the assembly’s resolution on antimicrobial resistance (AMR), which incorporates R&D as a vital part of WHO’s strategy to combat AMR. The statement also calls for WHO to accelerate efforts to develop accountability frameworks to ensure AMR commitments are realized. The statement was issued in partnership with the Global Health Council and PATH.

PDF
GHTC issues statement on R&D for epidemic diseases at WHO Executive Board meeting

GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board, welcoming efforts by WHO to advance frameworks to catalyze development of new technologies to combat potentially epidemic diseases and support regulatory models and procurement systems to accelerate the pace at which these tools reach patients. The statement was issued in partnership with the Global Health Council and PATH.

PDF
Devex
Global Health Technologies Coalition appoints new director

GHTC has named Jamie Bay Nishi as its new director. Currently, Ms. Nishi serves as Managing Director of Devex LIVE at Devex, a media platform for the global development community. She will assume the GHTC director position in late February.

Learn More
PATH/Rose Slavkovsky
GenomeWeb reports on GHTC advocacy for an essential diagnostics list

GenomeWeb reports on GHTC's call to World Health Organization to establish an essential diagnostics list, quoting GHTC policy officer Matt Robinson.

PDF
View All News
Devex
Global Health Technologies Coalition appoints new director

GHTC has named Jamie Bay Nishi as its new director. Currently, Ms. Nishi serves as Managing Director of Devex LIVE at Devex, a media platform for the global development community. She will assume the GHTC director position in late February.

Learn More
From AIDS to Zika, new report warns stagnant US funding for lifesaving tools against infectious disease threats leaves US and world at serious risk

Even as Congress grapples with the White House on how to fund an emergency response to fight Zika virus, a new report from GHTC warns that overall underfunding for development of lifesaving tools against neglected global diseases is putting the United States and the world at risk, and that emergency funding can’t be allowed to substitute for sustained US investment in research and development (R&D) of global health technologies.

Learn More
GHTC to host 4/19 Congressional briefing to unveil policy report

GHTC will launch its seventh annual policy report at an April 19 briefing on Capitol Hill. Some of the leading voices in global health will discuss policy actions the US government can take to accelerate development of urgently-needed tools to tackle existing and emerging health challenges, meet global health goals, and prepare today for the epidemics of tomorrow.

Learn More
Global Health Council joins GHTC

GHTC is excited to announce that the Global Health Council (GHC) has joined the coalition. GHC is the leading membership organization supporting and connecting advocates, implementers, and stakeholders around global health priorities worldwide.

Learn More
International Vaccine Institute joins GHTC

GHTC is pleased to announce that the International Vaccine Institute (IVI) has joined the coalition. IVI is an independent, nonprofit, international organization headquartered in Seoul, South Korea, that conducts research to discover, develop, and deliver safe, effective, and affordable vaccines for global public health.

Learn More
View All Announcements
PATH/Gabe Bienczycki
Research Roundup: Spillover and spillback, 3D spheres for drug development, drug resistance, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
GHTC/Matt Robinson
WHO Executive Board meeting closes with three shortlisted candidates to lead WHO and R&D issues added to WHA agenda

The 140th session of the World Health Organization (WHO) Executive Board (EB) closed last week with a shortlist of  three candidates for the WHO Director General position and progress on key global health R&D issues.

Read More
US Department of Agriculture/Lance Cheung
Research Roundup: Genetic mutations and innovative ways to package food aid

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Patrick McKern
WHO begins process to establish an essential diagnostics list following calls by GHTC and partners

We asked. WHO listened. The World Health Organization (WHO) took the first step toward establishing an essential diagnostics list, releasing a proposal outling how it plans to develop and operationalize the list by early 2019.

Read More
PATH/Katrina Peach
Research Roundup: Swine flu, drug resistance, and hepatitis C cures

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog
PATH/Rose Slavkovsky
GenomeWeb reports on GHTC advocacy for an essential diagnostics list

GenomeWeb reports on GHTC's call to World Health Organization to establish an essential diagnostics list, quoting GHTC policy officer Matt Robinson.

PDF
PATH/Satvir Malhotra
GHTC policy report cited in Huffington Post op-ed

GHTC's policy report Achieving a bold vision for global health: Policy solutions to advance global health R&D was cited in an op-ed in the Huffington Post on the tuberculosis epidemic.

View
PATH/Rose Slavkovsky
Infectious Disease News cites GHTC policy report

Infectious Disease News cites GHTC's policy report Achieving a bold vision for global health: Policy solutions to advance global health R&D in article exploring the role of public-private partnerships in fighting infectious diseases.

View
PATH/Gabe Bienczycki
CRS report cites GHTC policy report

The US Congressional Research Service cites findings from GHTC's policy report Achieving a bold vision for global health: Policy solutions to advance global health R&Din its report Zika Virus in Latin America and the Caribbean: U.S. Policy Considerations.

View
GHTC/GCSP
Intellectual Property Watch reports on GHTC event, webinar on global health R&D at WHA

Intellectual Property Watch highlights remarks made at a GHTC event and webinar on global health R&D issues on the World Health Assembly (WHA) agenda. 

View
View All GHTC in the Media
GHTC issues statement on CEWG follow-up, R&D observatory at WHO Executive board meeting

GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board welcoming progress by WHO in operationalizing a Global Observatory on Health Research and Development as a follow-up to the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG). The statement, which was issued in partnership with the Global Health Council, also encouraged member states to fully fund the observatory and recommended diverse global health stakeholders be consulted as the process moves forward.

PDF
GHTC issues statement on antimicrobial resistance at WHO Executive Board meeting

GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board supporting the assembly’s resolution on antimicrobial resistance (AMR), which incorporates R&D as a vital part of WHO’s strategy to combat AMR. The statement also calls for WHO to accelerate efforts to develop accountability frameworks to ensure AMR commitments are realized. The statement was issued in partnership with the Global Health Council and PATH.

PDF
GHTC issues statement on R&D for epidemic diseases at WHO Executive Board meeting

GHTC issued a statement at the 140th session of the World Health Organization (WHO) Executive Board, welcoming efforts by WHO to advance frameworks to catalyze development of new technologies to combat potentially epidemic diseases and support regulatory models and procurement systems to accelerate the pace at which these tools reach patients. The statement was issued in partnership with the Global Health Council and PATH.

PDF
GHTC sends letter urging WHO to establish an essential diagnostics list

GHTC sent a letter to the World Health Organization's (WHO) Assistant Director-General of  Health Systems and Innovation urging WHO to support the establishment of an essential diagnostics list.

PDF
GHTC sends FY18 letter to OMB

GHTC sent a letter to the White House Office of Management and Budget (OMB), calling for the incoming president to prioritize global health R&D in his or her fiscal year 2018 (FY18) budget.

PDF

Events

Member Event

PATH/Doune Porter
Community Discussion on the Reinstatement of the Mexico City Policy
Global Health Council
Learn More

Member Event

Global Health Council
The Future of Global Health 2017
Global Health Council
Learn More

Community Event

Consortium of Universities for Global Health
8th Annual CUGH Conference
Consortium of Universities for Global Health
Learn More
View All Current & Past Events

Stay Informed

Sign up to receive news and updates from GHTC.
Sign Up Now

Media Inquiries

Marissa Chmiola
Communications Officer
Global Health Technologies Coalition
mchmiola@ghtcoalition.org